263 related articles for article (PubMed ID: 24550004)
1. Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.
Vella KR; Ramadoss P; Costa-E-Sousa RH; Astapova I; Ye FD; Holtz KA; Harris JC; Hollenberg AN
Mol Cell Biol; 2014 May; 34(9):1564-75. PubMed ID: 24550004
[TBL] [Abstract][Full Text] [Related]
2. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Fozzatti L; Lu C; Kim DW; Park JW; Astapova I; Gavrilova O; Willingham MC; Hollenberg AN; Cheng SY
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17462-7. PubMed ID: 21987803
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.
Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE
Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486
[TBL] [Abstract][Full Text] [Related]
4. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice.
Alonso M; Goodwin C; Liao X; Ortiga-Carvalho T; Machado DS; Wondisford FE; Refetoff S; Weiss RE
Endocrinology; 2009 Aug; 150(8):3927-34. PubMed ID: 19406944
[TBL] [Abstract][Full Text] [Related]
5. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
6. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
[TBL] [Abstract][Full Text] [Related]
7. The thyroid axis is regulated by NCoR1 via its actions in the pituitary.
Costa-e-Sousa RH; Astapova I; Ye F; Wondisford FE; Hollenberg AN
Endocrinology; 2012 Oct; 153(10):5049-57. PubMed ID: 22878400
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.
Freudenthal B; Shetty S; Butterfield NC; Logan JG; Han CR; Zhu X; Astapova I; Hollenberg AN; Cheng SY; Bassett JHD; Williams GR
Thyroid; 2019 May; 29(5):726-734. PubMed ID: 30760120
[No Abstract] [Full Text] [Related]
9. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
[TBL] [Abstract][Full Text] [Related]
10. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo.
Machado DS; Sabet A; Santiago LA; Sidhaye AR; Chiamolera MI; Ortiga-Carvalho TM; Wondisford FE
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9441-6. PubMed ID: 19439650
[TBL] [Abstract][Full Text] [Related]
11. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone.
Ramos HE; Weiss RE
Thyroid; 2006 Mar; 16(3):211-6. PubMed ID: 16571082
[TBL] [Abstract][Full Text] [Related]
13. Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action.
Sadow PM; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Weiss RE
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E36-46. PubMed ID: 12388168
[TBL] [Abstract][Full Text] [Related]
14. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.
Astapova I; Lee LJ; Morales C; Tauber S; Bilban M; Hollenberg AN
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19544-9. PubMed ID: 19052228
[TBL] [Abstract][Full Text] [Related]
15. Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone.
Ying H; Furuya F; Willingham MC; Xu J; O'Malley BW; Cheng SY
Mol Cell Biol; 2005 Sep; 25(17):7687-95. PubMed ID: 16107715
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis.
Astapova I; Vella KR; Ramadoss P; Holtz KA; Rodwin BA; Liao XH; Weiss RE; Rosenberg MA; Rosenzweig A; Hollenberg AN
Mol Endocrinol; 2011 Feb; 25(2):212-24. PubMed ID: 21239618
[TBL] [Abstract][Full Text] [Related]
17. Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.
Reutrakul S; Sadow PM; Pannain S; Pohlenz J; Carvalho GA; Macchia PE; Weiss RE; Refetoff S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3609-17. PubMed ID: 11061510
[TBL] [Abstract][Full Text] [Related]
18. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M
Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262
[TBL] [Abstract][Full Text] [Related]
19. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM
Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736
[TBL] [Abstract][Full Text] [Related]
20. Assessing the clinical and molecular diagnosis of inherited forms of impaired sensitivity to thyroid hormone from a single tertiary center.
Ramos LS; Kizys MML; Kunii IS; Spinola-Castro AM; Nesi-França S; Guerra RA; Camacho CP; Martins JRM; Maciel RMB; Dias-da-Silva MR; Chiamolera MI
Endocrine; 2018 Dec; 62(3):628-638. PubMed ID: 30027432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
